Search

Supplemental material, sj-doc-1-taj-10.1177_20406223221093758 for Non-inferiority of 1 month versus longer dual antiplatelet therapy in patients undergoing PCI with drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials by Gani Bajraktari, Ibadete Bytyçi, Artan Bajraktari and Michael Y. Henein in Therapeutic Advances in Chronic Disease

It has been demonstrated that pre-hospital emergency care reduces in-hospital mortality in patients admitted with acute coronary syndrome (ACS). The aim of this study was to analyze the relationship between pre-hospital emergency care and in-hospital mortality in ACS patients treated at the University Clinical Centre of Kosovo Emergency Department (UCCK ED). This observational clinical study included 1498 ACS patients treated at UCCK ED and followed-up by phone call for one year after discharge from the hospital. According to multivariate Cox regression analysis, age (HR=2.37, 95% CI 1.67-3.52), pre-hospital emergency care (HR=3.92, 95% CI 2.35-6.54), STEMI (HR=6.17, 95% CI 3.22-15.31), diabetes mellitus (HR=3.01, 95% CI 1.98-3.78), left ventricular ejection fraction, Pokazano je da predbolnička hitna skrb smanjuje bolničku smrtnost u bolesnika s akutnim koronarnim sindromom (AKS). Cilj ove studije bio je analizirati odnos između predbolničke hitne skrbi i bolničke smrtnosti bolesnika s AKS-om liječenih na Odjelu za hitne slučajeve Univerzitetskog kliničkog centra Kosova (UKCK). Ovo opservacijsko kliničko istraživanje obuhvaćalo je 1498 bolesnika s AKS-om liječenih na Odjelu za hitne slučajeve UKCK, koji su praćeni godinu dana nakon otpusta telefonskim pozivom. Multivarijatna Coxova regresijska analiza pokazala je da su dob (HR=2,37, 95% CI 1,67-3,52), predbolnička hitna skrb (HR=3,92, 95% CI 2,35-6,54), STEMI (HR=6,17, 95% CI 3,22-15,31), šećerna bolest (HR=3,01, 95% CI 1,98-3,78), istisna frakcija lijeve klijetke

Additional file 1: Appendix 1. Assessment of risk of bias in the included studies using Cochrane criteria for RCTs. Appendix 2. Assessment of risk of bias in the included studies using Newcastle-Ottawa Quality Assessment Scale (NOS) for cohort studies. Figure S1. Association of statin versus non-statin use with all-cause mortality in heart failure only in cohort studies. Figure. S2. Association of statin versus non-statin use with CV mortality in heart failure only in cohort studies. Figure S3. Association of statin versus non-statin use hospitalization in heart failure only in cohort studies. Figure S4. Association of statin versus non-statin use with all-cause mortality by type of heart failure only in cohort studies. Figure S5. Association of statin versus non-statin use with CV mortality by type of heart failure only in cohort studies. Figure S6. Association of statin versus non-statin use with hospitalization by type of heart failure only in cohort studies. Table S1. Assessment of risk of bias in the included studies using Cochrane criteria for RCTs. Table S2. Assessment of risk of bias in the included studies using Newcastle-Ottawa Quality Assessment Scale (NOS) for cohort studies.

The Minnesota Living with Heart Failure Questionnaire. (DOC 29 kb)